Related Experiment Video

Updated: Oct 5, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

877

Emergency Department Management of Hypertension in the Context of COVID-19

Sara W Heinert1, Renee Riggs2, Heather Prendergast3

  • 1Department of Emergency Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA. sara.heinert@rutgers.edu.

Current Hypertension Reports
|January 25, 2022
PubMed

Insights

Patients with hypertension face increased COVID-19 risks. Emergency care for hypertensive patients requires considering pandemic-related socioeconomic factors and medication safety, as ACE inhibitors/ARBs show neutral or improved outcomes.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Hypertension (HTN) is a significant comorbidity associated with severe COVID-19 outcomes.
  • The COVID-19 pandemic introduced unique challenges to managing chronic conditions like HTN.
  • Socioeconomic factors and demographic variables influence HTN patient outcomes during pandemics.

Purpose of the Study:

  • To review the relationship between COVID-19 and hypertension.
  • To outline considerations for emergency medicine providers in managing hypertensive patients during the COVID-19 pandemic.

Main Methods:

  • Review of existing literature on COVID-19 and hypertension.
  • Analysis of demographic and socioeconomic factors impacting patient outcomes.
  • Evaluation of antihypertensive medication effects, specifically ACE inhibitors/ARBs.

Main Results:

  • Hypertensive patients exhibit higher risks for severe COVID-19, hospitalization, ICU admission, and mortality.
  • Use of ACE inhibitors/ARBs is linked to neutral or improved COVID-19 outcomes, contrary to initial concerns.
  • Socioeconomic factors, including healthcare access barriers and fear of infection, complicate patient management.

Conclusions:

  • Emergency medicine providers must consider the heightened risks and unique management challenges for hypertensive patients during the COVID-19 pandemic.
  • Pandemic-related stressors and access barriers significantly impact chronic disease management.
  • Continued vigilance and tailored care are essential for hypertensive patients in public health crises.
Abstract

Keywords:
COVID-19Chronic disease managementEmergency departmentHypertensionSocioeconomic factors

More Related Videos

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

30.7K
Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients08:45

Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients

Published on: April 18, 2025

483

Related Concept Videos

Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
62
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.3K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
123
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
69
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
95
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
40